The United Arab Emirates (UAE) is rapidly emerging as a global hub for life sciences and clinical research. Driven by UAE Centennial 2071 and the National Strategy for Wellbeing 2031, the Ministry of Health and Prevention (MoHAP) and authorities like the Department of Health (DOH) Abu Dhabi and Dubai Health Authority (DHA) are aggressively adopting Decentralized Clinical Trials (DCTs). This shift necessitates robust Clinical Trial Telehealth Platforms that can bridge the gap between researchers and participants across the seven emirates.
Platforms must adhere to strict UAE Federal Law No. 2 of 2019 regarding the use of Information and Communication Technology in Healthcare (Health Data Law).
Focusing on world-class healthcare, the UAE market demands technologies that support genetic research and precision medicine through remote data capture.
With 5G penetration reaching nearly 100%, the UAE is uniquely positioned for high-bandwidth telehealth and real-time biometric streaming.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, and healthcare institutions worldwide.
The company's product portfolio includes wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, and digital research tools. These are designed to facilitate real-time data collection, improve participant engagement, and streamline study management in complex regulatory environments like the UAE.
As the "World's Factory," Dongguan offers unparalleled supply chain integration. For Clinical Trial Telehealth Platforms, this means:
Our solutions are not "one size fits all." We provide localization specific to the UAE market:
Procuring Clinical Trial Telehealth Platforms involves complex stakeholders. Our solutions cater to:
Accelerate "Time to Market" by reducing trial durations through remote enrollment and monitoring.
Manage multi-center trials across Abu Dhabi, Dubai, and Sharjah from a single centralized dashboard.
Implementing national-level health data studies with high security and scalability.
Cost-effective digital tools for niche clinical studies in university hospitals.
Our platforms integrate advanced Data Capture Cards (e.g., ZMOTION ECI0016PA) and encrypted communication modules to ensure that clinical data remains tamper-proof—a critical requirement for FDA, EMA, and MoHAP auditing.
Our platforms are built with a "Privacy by Design" approach. We ensure all data collected within the UAE is stored on local servers (compliant with MoHAP requirements) and utilize end-to-end AES-256 encryption for both data at rest and in transit.
Yes, as a manufacturer with over 11,000 SQM of production space, we provide full OEM/ODM services. We can customize wearable sensors, power adapters, and patient tablets to meet the specific biometric needs of your study.
Leveraging major logistics hubs in Shenzhen and Hong Kong, standard medical components can be delivered within 5-7 working days. Larger system integrations and custom hardware typically have a lead time of 4-6 weeks.
Absolutely. Our nurse call systems and portable ECG devices are designed to synchronize data between traditional hospital wards and at-home patient monitoring devices, providing a unified data stream for investigators.
All our outdoor and portable medical devices undergo rigorous thermal testing. We use high-grade industrial polymers and heat-dissipating PCB designs to ensure 24/7 reliability in environments reaching up to 50°C.
Trial Medical
